Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'IZOPET J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 106 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ben Halima, M; Pasquier, C; Slim, A; Ben Chaabane, T; Arrouji, Z; Puel, J; Ben Redjeb, S; Izopet, J
      First molecular characterization of HIV-1 Tunisian strains

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Masquelier, B; Chaix, ML; Burgard, M; Lechenadec, J; Doussin, A; Simon, F; Cottalorda, J; Izopet, J; Tamalet, C; Douard, D; Fleury, H; Mayaux, MJ; Blanche, S; Rouzioux, C
      Zidovudine genotypic resistance in HIV-1-infected newborns in the French Perinatal Cohort

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    3. Sandres, K; Dubois, M; Pasquier, C; Puel, J; Izopet, J
      Determination of HCV genotype using two antibody assays and genome typing

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    4. Kamar, N; Kany, M; Bories, P; Ribes, D; Izopet, J; Durand, D; Rostaing, L
      Reversible posterior leukoencephalopathy syndrome in hepatitis C virus-positive long-term hemodialysis patients

      AMERICAN JOURNAL OF KIDNEY DISEASES
    5. Descamps, D; Calvez, V; Izopet, J; Bluffet-Janvresse, C; Schmuck, A; Colson, P; Ruffault, A; Maillard, A; Masquelier, B; Cottalorda, J; Harzic, M; Brun-Vezinet, F; Costagliola, D
      Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study

      AIDS
    6. Alric, L; Duffaut, M; Selves, J; Sandre, K; Mularczyck, M; Izopet, J; Desmorat, H; Bureau, C; Chaouche, N; Dalbergue, B; Vinel, JP
      Maintenance therapy with gradual reduction of the interferon dose over oneyear improves histological response in patients with chronic hepatitis C with biochemical response: results of a randomized trial

      JOURNAL OF HEPATOLOGY
    7. Pasquier, C; Millot, N; Njouom, R; Sandres, K; Cazabat, M; Puel, J; Izopet, J
      HIV-1 subtyping using phylogenetic analysis of pol gene sequences

      JOURNAL OF VIROLOGICAL METHODS
    8. Goulder, PJR; Pasquier, C; Holmes, EC; Liang, B; Tang, YH; Izopet, J; Saune, K; Rosenberg, ES; Burchett, SK; McIntosh, K; Barnardo, M; Bunce, M; Walker, BD; Brander, C; Phillips, RE
      Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation

      IMMUNOLOGY LETTERS
    9. Masquelier, B; Race, E; Tamalet, C; Descamps, D; Izopet, J; Buffet-Janvresse, C; Ruffault, A; Mohammed, AS; Cottalorda, J; Schmuck, A; Calvez, V; Dam, E; Fleury, H; Brun-Vezinet, F
      Genotypic and penotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase(RT): Multicenter study of patients treated with RT inhibitors

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    10. Hance, AJ; Lemiale, V; Izopet, J; Lecossier, D; Joly, V; Massip, P; Mammano, F; Descamps, D; Brun-Vezinet, F; Clavel, F
      Changes in human immunodeficiency virus type 1 populations after treatmentinterruption in patients failing antiretroviral therapy

      JOURNAL OF VIROLOGY
    11. Pellegrin, I; Segondy, M; Garrigue, I; Izopet, J; Montes, B; Pellegrin, JL; Reynes, J; Massip, P; Puel, J; Fleury, H
      Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    12. Malavaud, B; Dinh, B; Bonnet, E; Izopet, J; Payen, JL; Marchou, B
      Increased incidence of indinavir nephrolithiasis in patients with hepatitis B or C virus infection

      ANTIVIRAL THERAPY
    13. Burgard, M; Izopet, J; Dumon, B; Tamalet, C; Descamps, D; Ruffault, A; Vabret, A; Bargues, G; Mouroux, M; Pellegrin, I; Ivanoff, S; Guisthau, O; Calvez, V; Seigneurin, JM; Rouzioux, C
      HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    14. Mouroux, M; Izopet, J; Descamps, D; Delaugerre, C; Yvon-Groussin, A; Angleraud, F; Coutellier, A; Bonmarchand, M; Valantin, MA; Matheron, S; Agut, H; Katlama, C; Brun-Vezinet, F; Calvez, V
      Conditions of selection of 'thymidine analogue mutations' (TAMs) in naive patients receiving different antiretroviral combinations including d4T.

      PATHOLOGIE BIOLOGIE
    15. Izopet, J; Massip, P; Souyris, C; Sandres, K; Puissant, B; Obadia, M; Pasquier, C; Bonnet, E; Marchou, B; Puel, J
      Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen

      AIDS
    16. Pasquier, C; Daudin, M; Righi, L; Berges, L; Thauvin, L; Berrebi, A; Massip, P; Puel, J; Bujan, L; Izopet, J
      Sperm washing and virus nucleic acid detection to reduce HIV and hepatitisC virus transmission in serodiscordant couples wishing to have children

      AIDS
    17. Lesourd, F; Izopet, J; Mervan, C; Payen, JL; Sandres, K; Monrozies, X; Parinaud, J
      Transmissions of hepatitis C virus during the ancillary procedures for assisted conception

      HUMAN REPRODUCTION
    18. Causse, X; Payen, JL; Izopet, J; Babany, G; Girardin, MFS
      Does HIV-infection influence the response of chronic hepatitis C to interferon treatment? A French multicenter prospective study

      JOURNAL OF HEPATOLOGY
    19. Lefrere, JJ; Lerable, J; Mariotti, M; Bogard, M; Thibault, V; Frangeul, L; Loiseau, P; Bouchardeau, F; Laperche, S; Pawlotsky, JM; Cantaloube, JF; Biagini, P; de Lamballerie, X; Izopet, J; Defer, C; Lepot, I; Poveda, JD; Dussaix, E; Gerolami, V; Halfon, P; Buffet-Janvresse, C; Ferec, C; Mercier, B; Marcellin, P; Martinot-Peignoux, M; Gassain, M; Merel, P; Lamoril, J; Coste, J; Roudet-Thoraval, F
      Lessons from a multicentre study of the detectability of viral genomes based on a two-round quality control of GB virus C (GBV-C)/hepatitis G virus (HGV) polymerase chain reaction assay

      JOURNAL OF VIROLOGICAL METHODS
    20. Tamalet, C; Pasquier, C; Yahi, N; Colson, P; Poizot-Martin, I; Lepeu, G; Gallais, H; Massip, P; Puel, J; Izopet, J
      Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection

      JOURNAL OF MEDICAL VIROLOGY
    21. Salama, G; Rostaing, L; Sandres, K; Izopet, J
      Hepatitis C virus infection in French hemodialysis units: A multicenter study

      JOURNAL OF MEDICAL VIROLOGY
    22. Rostaing, L; Izopet, J; Sandres, K; Cisterne, JM; Puel, J; Durand, D
      Changes in hepatitis C virus RNA viremia concentrations int long-term renal transplant patients after introduction of mycophenolate mofetil

      TRANSPLANTATION
    23. Sandres, K; Dubois, M; Pasquier, C; Payen, JL; Alric, L; Duffaut, M; Vinel, JP; Pascal, JP; Puel, J; Izopet, J
      Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy

      JOURNAL OF VIROLOGY
    24. Izopet, J; Rostaing, L; Sandres, K; Cisterne, JM; Pasquier, C; Rumeau, JL; Duffaut, M; Durand, D; Puel, J
      Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients

      JOURNAL OF INFECTIOUS DISEASES
    25. Alric, L; Fort, M; Izopet, J; Vinel, JP; Bureau, C; Sandre, K; Charlet, JP; Beraud, M; Abbal, M; Duffaut, M
      Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance

      TISSUE ANTIGENS
    26. Reynes, J; Denisi, R; Massip, P; Izopet, J; Pellegrin, I; Segondy, M
      Once-daily administration of didanosine in combination with stavudine in antiretroviral-naive patients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    27. Masquelier, B; Descamps, D; Carriere, I; Ferchal, F; Collin, G; Denayrolles, M; Ruffault, A; Chanzy, B; Izopet, J; Buffet-Janvresse, C; Schmitt, MP; Race, E; Fleury, HJA; Aboulker, JP; Yeni, P; Brun-Vezinet, F
      Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the Delta lamivudine roll-over study

      ANTIVIRAL THERAPY
    28. Martinot-Peignoux, M; Roudot-Thoraval, F; Mendel, I; Coste, J; Izopet, J; Duverlie, G; Payan, C; Pawlotsky, JM; Defer, C; Bogard, M; Gerolami, V; Halfon, P; Buisson, Y; Fouqueray, B; Loiseau, P; Lamoril, J; Lefrere, JJ; Marcellin, P
      Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy

      JOURNAL OF VIRAL HEPATITIS
    29. Chatelut, E; Rostaing, L; Gregoire, N; Payen, JL; Pujol, A; Izopet, J; Houin, G; Canal, P
      A pharmacokinetic model for alpha interferon administered subcutaneously

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    30. Malavaud, B; Miedouge, M; Payen, JL; Izopet, J; Rischmann, P; Pascal, JP; Sarramon, JP; Serre, G
      Prostate-specific antigen in acute hepatitis and hepatocellular carcinoma

      PROSTATE
    31. Pellegrin, I; Izopet, J; Reynes, J; Denayrolles, M; Montes, B; Pellegrin, JL; Massip, P; Puel, J; Fleury, H; Segondy, M
      Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plusdidanosine combination therapy

      AIDS
    32. Rostaing, L; Izopet, J; Arnaud, C; Rumeau, JL; Duffaut, M; Cisterne, JM; Durand, D
      Long-term impact of co-infection by hepatitis G virus in hepatitis C viruspositive renal transplant patients

      NEPHROLOGIE
    33. Alric, L; Izopet, J; Fort, M; Vinel, JP; Fontenelle, P; Orfila, C; Payen, JL; Sandres, K; Desmorat, H; Charlet, JP; Duffaut, M; Abbal, M
      Study of the association between major histocompatibility complex class IIgenes and the response to interferon alpha in patients with chronic hepatitis C infection

      HUMAN IMMUNOLOGY
    34. Pasquier, C; Sandres, K; Salama, G; Puel, J; Izopet, J
      Using RT-PCR and bDNA assays to measure non-clade BHIV-1 subtype RNA

      JOURNAL OF VIROLOGICAL METHODS
    35. Izopet, J; Bicart-See, A; Pasquier, C; Sandres, K; Bonnet, E; Marchou, B; Puel, J; Massip, P
      Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine

      JOURNAL OF MEDICAL VIROLOGY
    36. Izopet, J; Pasquier, C; Sandres, K; Puel, J; Rostaing, L
      Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit

      JOURNAL OF MEDICAL VIROLOGY
    37. Izopet, J; Sailler, L; Sandres, K; Pasquier, C; Bonnet, E; Aquilina, C; Puel, J; Massip, P; Marchou, B
      Intermittent selection pressure with zidovudine plus zalcitabine treatmentreduces the emergence in vivo of zidovudine resistance HIV mutations

      JOURNAL OF MEDICAL VIROLOGY
    38. Rostaing, L; Izopet, J; Arnaud, C; Cisterne, JM; Alric, L; Rumeau, JL; Duffaut, M; Durand, D
      Long-term impact of superinfection by hepatitis G virus in hepatitis C virus-positive renal transplant patients

      TRANSPLANTATION
    39. Alric, L; Fort, M; Izopet, J; Vinel, JP; Duffaut, M; Abbal, M
      Association between genes of the major histocompatibility complex class IIand the outcome of hepatitis C virus infection

      JOURNAL OF INFECTIOUS DISEASES
    40. Izopet, J; Salama, G; Pasquier, C; Sandres, K; Marchou, B; Massip, T; Puel, J
      Decay of HIV-1 DNA in patients receiving suppressive antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    41. ROSTAING L; CHATELUT E; PAYEN JL; IZOPET J; THALAMAS C; TONTHAT H; PASCAL JP; DURAND D; CANAL P
      PHARMACOKINETICS OF ALPHA-IFN-2B IN CHRONIC HEPATITIS-C VIRUS PATIENTS UNDERGOING CHRONIC-HEMODIALYSIS OR WITH NORMAL RENAL-FUNCTION - CLINICAL IMPLICATIONS

      Journal of the American Society of Nephrology
    42. BELLO PY; PASQUIER C; GOURNEY P; PUEL J; IZOPET J
      ASSESSMENT OF A HEPATITIS-C VIRUS-ANTIBODY ASSAY IN SALIVA FOR EPIDEMIOLOGIC STUDIES

      European journal of clinical microbiology & infectious diseases
    43. PASQUIER C; IZOPET J; PUEL J
      THE CONTRIBUTION OF MOLECULAR VIROLOGY TO THE UNDERSTANDING OF HIV-1 MOTHER-TO-CHILD TRANSMISSION

      MS. Medecine sciences
    44. ROSTAING L; IZOPET J; MODESTOSEGONDS A
      HEPATITIS-C AFTER RENAL-TRANSPLANTATION

      La Presse medicale
    45. PAYEN JL; IZOPET J; BARANGE K; PUEL J; SELVES J; PASCAL JP
      HEPATITIS-C REINFECTION AFTER INTRAVENOUS DRUG INJECTION

      Gastroenterologie clinique et biologique
    46. COMBIS JM; DESMORAT H; IZOPET J; BARANGE K; PAYEN JL; DANTIN S; MERICQ O; DUFFAUT M; VINEL JP; PASCAL JP
      OFLOXACINE (OFL) AND INTERFERON-ALPHA (IFN) TREATMENT OF CHRONIC HEPATITIS-C - A PILOT-STUDY

      Hepatology
    47. Payen, JL; Izopet, J; Galindo-Migeot, V; Lauwers-Cances, V; Zarski, JP; Seigneurin, JM; Dussaix, E; Voigt, JJ; Selves, J; Barange, K; Puel, J; Pascal, JP
      Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: A multicenter,controlled, randomized trial

      HEPATOLOGY
    48. TAMALET C; IZOPET J; KOCH N; FANTINI J; YAHI N
      STABLE REARRANGEMENTS OF THE BETA-3-BETA-4 HAIRPIN LOOP OF HIV-1 REVERSE-TRANSCRIPTASE IN PLASMA VIRUSES FROM PATIENTS RECEIVING COMBINATION THERAPY

      AIDS
    49. ALRIC L; OSKMAN F; SANMARCO M; IZOPET J; BONNET E; GARCIARICART F; VINEL JP; DUFFAUT M
      ASSOCIATION OF ANTIPHOSPHOLIPID SYNDROME AND CHRONIC HEPATITIS-C

      British journal of rheumatology
    50. ROSTAING L; MODESTO A; CISTERNE JM; IZOPET J; OKSMAN F; DUFFAUT M; ABBAL M; DURAND D
      SEROLOGICAL MARKERS OF AUTOIMMUNITY IN RENAL-TRANSPLANT PATIENTS WITHCHRONIC HEPATITIS-C

      American journal of nephrology
    51. IZOPET J; PAYEN JL; ALRIC L; SANDRES K; CHARLET JP; VINEL JP; DUFFAUT M; PASCAL JP; PUEL J
      BASE-LINE LEVEL AND EARLY SUPPRESSION OF SERUM HCV RNA FOR PREDICTINGSUSTAINED COMPLETE RESPONSE TO ALPHA-INTERFERON THERAPY

      Journal of medical virology
    52. IZOPET J; TAMALET C; PASQUIER C; SANDRES K; MARCHOU B; MASSIP P; PUEL J
      QUANTIFICATION OF HIV-1 PROVIRAL DNA BY A STANDARDIZED COLORIMETRIC PCR-BASED ASSAY

      Journal of medical virology
    53. SEGONDY M; IZOPET J; PELLEGRIN I; MONTES B; DUMON B; PASQUIER C; PEETERS M; FLEURY HJA; PUEL J; REYNES J
      COMPARISON OF THE QUANTIPLEX HIV-1 RNA-2.0 ASSAY WITH THE AMPLICOR HIV-1 MONITOR-1.0 ASSAY FOR QUANTITATION OF LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA IN PLASMA OF PATIENTS RECEIVING STAVUDINE-DIDANOSINE COMBINATION THERAPY

      Journal of clinical microbiology (Print)
    54. ROSTAING L; IZOPET J; CISTERNE JM; ARNAUD C; DUFFAUT M; RUMEAU JL; PUEL J; DURAND D
      IS LONG-TERM CHRONIC IMMUNOSUPPRESSION THERAPY DETRIMENTAL IN HEPATITIS-C VIRUS-POSITIVE RENAL-TRANSPLANT PATIENTS

      Transplantation proceedings
    55. ROSTAING L; IZOPET J; CISTERNE JM; ARNAUD C; DUFFAUT M; RUMEAU JL; PUEL J; DURAND D
      IMPACT OF HEPATITIS-C VIRUS DURATION AND HEPATITIS-C VIRUS GENOTYPES ON RENAL-TRANSPLANT PATIENTS

      Transplantation
    56. PASQUIER C; CAYROU C; BLANCHER A; TOURNEPETHEIL C; BERREBI A; TRICOIRE J; PUEL J; IZOPET J
      MOLECULAR EVIDENCE FOR MOTHER-TO-CHILD TRANSMISSION OF MULTIPLE VARIANTS BY ANALYSIS OF RNA AND DNA-SEQUENCES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      Journal of virology (Print)
    57. DUVERLIE G; KHORSI H; CASTELAIN S; JAILLON O; IZOPET J; LUNEL F; EB F; PENIN F; WYCHOWSKI C
      SEQUENCE-ANALYSIS OF THE NS5A PROTEIN OF EUROPEAN HEPATITIS-C VIRUS 1B ISOLATES AND RELATION TO INTERFERON SENSITIVITY

      Journal of General Virology
    58. PASQUIER C; BELLO PY; GOURNEY P; PUEL J; IZOPET J
      A NEW-GENERATION OF SERUM ANTI-HIV ANTIBODY IMMUNOCAPTURE ASSAY FOR SALIVA TESTING

      Clinical and diagnostic virology
    59. LAFEUILLADE A; TAMALET C; POGGI C; PELLEGRINO P; TOURRES C; IZOPET J
      ANTIRETROVIRAL EFFECT OF ZIDOVUDINE-DIDANOSINE COMBINATION ON BLOOD AND LYMPH-NODES

      AIDS
    60. IZOPET J; ROSTAING L; TONTHAT H; DUBOIS M; CAZABAT M; CHARLET JP; SAYADA C; DUFFAUT M; DURAND D; PUEL J
      KINETICS OF HCV VIREMIA IN KIDNEY-TRANSPLANT RECIPIENTS DURING AND AFTER ALPHA-INTERFERON THERAPY

      American journal of nephrology
    61. ROSTAING L; IZOPET J; CISTERNE JM; ICART J; CHABANNIER MH; PANICALI H; DURAND D
      PREVALENCE OF ANTIBODIES TO HEPATITIS-C VIRUS AND CORRELATION WITH LIVER-DISEASE IN RENAL-TRANSPLANT PATIENTS

      American journal of nephrology
    62. ROSTAING L; IZOPET J; MOUSSION F; ALRIC L; VERDIER D; THAT HT; DUFFAUT M; DURAND D; PUEL J; SUC JM
      HCV RNA CLEARANCE BY HEMODIALYSIS-PATIENT S WITH AND WITHOUT HGV HGBV-C INFECTION AFTER ALPHA-INTERFERON-THERAPY/

      Nephrologie
    63. HALFON P; POL S; SAYADA C; IZOPET J; ROSTAING L; OUZAN D
      CLINICAL-SIGNIFICANCE OF HCV RNA DETECTIO N AND QUANTITATION IN HEMODIALYSIS-PATIENTS - PROPOSAL FOR A RATIONAL DIAGNOSTIC STRATEGY

      Nephrologie
    64. KHORSI H; CASTELAIN S; WYSEUR A; IZOPET J; CANVA V; ROMBOUT A; CAPRON D; CAPRON JP; LUNEL F; STUYVER L; DUVERLIE G
      MUTATIONS OF HEPATITIS-C VIRUS 1B NS5A-2209-2248 AMINO-ACID-SEQUENCE DO NOT PREDICT THE RESPONSE TO RECOMBINANT INTERFERON-ALFA THERAPY IN FRENCH PATIENTS

      Journal of hepatology
    65. BRUNVEZINET F; BOUCHER C; LOVEDAY C; DESCAMPS D; FAUVEAU V; IZOPET J; JEFFRIES D; KAYE S; KRZYANOWSKI C; NUNN A; SCHUURMAN R; SEIGNEURIN JM; TAMALET C; TEDDER R; WEBER J; WEVERLING GJ; ABER V; ABOULKER JP; BABIKER AG; BRAGMAN K; BRECKENRIDGE AM; CARBON C; CHARREAU I; CHENE G; COLLIS P; COOPER D; DARBYSHIRE JH; DORMONT J; FIDDIAN P; FLEPP M; GAZZARD B; GOEBEL FD; HOOKER M; LANGE J; LUTHY R; PETO TEA; REISS P; SELIGMANN M; STONE AB; THOMIS J; VELLA S; WALCKENAER G; WARRELL D; WELLER IVD; WILBER R; YENI P; YEO J; WITHNALL R; BABIKER A; BLOCH J; POUCHER C; DARBYSHIRE J; GOUDSMIT J; HURAUX JM; VANDERNOORDAA J; WEISS R; WEVERLING G
      HIV-1 VIRAL LOAD, PHENOTYPE, AND RESISTANCE IN A SUBSET OF DRUG-NAIVEPARTICIPANTS FROM THE DELTA-TRIAL

      Lancet
    66. BOGARD M; BUFFETJANVRESSE C; CANTALOUBE JF; BIAGINI P; DUVERLIE G; CASTELAIN S; IZOPET J; DUBOIS M; DEFER C; LEPOT I; COSTE J; MARCELLIN P; MARTINOTPEIGNOUX M; HALFON P; GEROLAMI V; FRANGUEL L; PAWLOTSKY JM; ROUDOTTHORAVAL F; DUSSAIX E; LOISEAU P; RAVERA N; LEWIN P; LAMORIL J; LERABLE J; BOUCHARDEAU F; LAPERCHE S; MARIOTTI M; LEFRERE JJ; NICOT T; DENIS F; GASSAIN M; MEREL P; TREPO C; THIERS V; BRECHOT C; FEREC C; MERCIER B; STOLLKELLER F; PALMER P; LEBON P
      GEMHEP MULTICENTER QUALITY-CONTROL STUDY OF PCR DETECTION OF GB-VIRUS-C HEPATITIS-G VIRUS-RNA IN SERUM

      Journal of clinical microbiology
    67. IZOPET J; ROSTAING L; MOUSSION F; ALRIC L; DUBOIS M; THAT HT; PAYEN JL; DUFFAUT M; DURAND D; SUE JM; PUEL J
      HIGH-RATE OF HEPATITIS-C VIRUS CLEARANCE IN HEMODIALYSIS-PATIENTS AFTER INTERFERON-ALPHA THERAPY

      The Journal of infectious diseases
    68. ALRIC L; FORT M; IZOPET J; VINEL JP; CHARLET JP; SELVES J; PUEL J; PASCAL JP; DUFFAUT M; ABBAL M
      GENES OF THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II INFLUENCE THE OUTCOME OF HEPATITIS-C VIRUS-INFECTION

      Gastroenterology
    69. ALRIC L; ABBAL M; IZOPET J; CHARLET JP; VINEL JP; GIRARDIN MFS; DUFFAUT M
      GENES OF THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II INFLUENCE THE OUTCOME OF HEPATITIS-C VIRUS-INFECTION

      Gastroenterology
    70. Khorsi, H; Stuyver, L; Castelain, S; Wyseur, A; Izopet, J; Capron, D; Capron, JP; Duverlie, G
      Response to interferon and mutations in the NS5A gene in HCV-1b infection:preliminary study of the ISDR of French patients

      HEPATITIS C VIRUS: GENETIC HETEROGENEITY AND VIRAL LOAD
    71. IZOPET J; ROSTAING L; SANDRES K; ALLAL A; PASQUIER C; DUBOIS M; DUPRE C; THAT HT; SUC JM; PUEL J
      IMPACT OF HGV INFECTION IN HEMODIALYSIS-PATIENTS

      Journal of the American Society of Nephrology
    72. ROSTAING L; IZOPET J; DUFFAUT M; RUMEAU JL; CISTERNE JM; ALRIC L; PUEL J; DURAND D
      LIVER HOSTOLOGY, HEPATITIS-C VIRUS-HCV-GENOTYPE AND VIREMIA IN HCV-TRANSPLANT (RT) PATIENTS(VE RENAL)

      Journal of the American Society of Nephrology
    73. ROSTAING L; MODESTOSEGONS A; CISTERNE JM; IZOPET J; DURAND D; SUC JM
      RENAL-ALLOGRAFT GLOMERULOPATHY IN HEPATITIS-C VIRUS (HCV)-TRANSPLANT (KT) PATIENTS(VE KIDNEY)

      Journal of the American Society of Nephrology
    74. CISTERNE JM; ROSTAING L; IZOPET J; CHABANNIER MH; BARON E; DUFFAUT M; DURAND D; SUC JM
      EPIDEMIOLOGY OF HCV INFECTION - DISEASE AND RENAL-TRANSPLANTATION

      Nephrology, dialysis, transplantation
    75. PAYEN JL; IZOPET J
      DOES A HEALTHY CARRIER OF HEPATITIS-C VIR US EXIST

      Gastroenterologie clinique et biologique
    76. KHORSI H; STUYVER L; CASTELAIN S; WYSEUR A; IZOPET J; CAPRON D; CAPRON JP; DUVERLIE G
      INTERFERON SENSITIVITY DETERMINING REGION (ISDR) IN FRENCH HEPATITIS-C VIRUS 1B CHRONICALLY INFECTED PATIENTS

      Hepatology
    77. PAYEN JL; IZOPET J; GALINDO V; ZARSKI JP; SEIGNEURIN JM; DUSSAIX E; LANGLOIS C; VINEL JP; BARANGE K; PUEL J; PASCAL JP
      COMPARISON OF 3 INTERFERON ALFA-2B REGIMENS FOR RETREATMENT (RTT) OF PATIENTS WITH CHRONIC HEPATITIS-C WITH PRIOR COMPLETE RESPONSE FOLLOWED BY RELAPSE - A CONTROLLED, RANDOMIZED TRIAL

      Hepatology
    78. IZOPET J; PAYEN JL; ZARSKI JP; SEIGNEURIN JM; DUSSAIX E; LANGLOIS C; SAYADA C; DUBOIS M; ALRIC L; BARANGE K; VINEL JP; PASCAL JP; PUEL J
      QUANTIFICATION OF HEPATITIS-C VIRUS-RNA BY RT-PCR - MULTICENTER QUALITY CHECK

      Hepatology
    79. ROSTAING L; OKSMAN F; IZOPET J; BARON E; CISTERNE JM; HOFF M; ABBAL M; DURAND D
      SEROLOGICAL MARKERS OF AUTOIMMUNITY IN RENAL-TRANSPLANT PATIENTS BEFORE AND AFTER ALPHA-INTERFERON THERAPY FOR CHRONIC HEPATITIS-C

      American journal of nephrology
    80. IZOPET J; POGGI C; DUSSAIX E; MANSUY JM; CUBAYNES L; PROFIZI N; LAFEUILLADE A; MARCHOU B; MASSIP P; SAYADA C; PUEL J
      ASSESSMENT OF A STANDARDIZED REVERSE-TRANSCRIPTASE PCR ASSAY FOR QUANTIFYING HIV-1 RNA IN PLASMA AND SERUM

      Journal of virological methods
    81. LINA B; POZZETTO B; ANDREOLETTI L; BEGUIER E; BOURLET T; DUSSAIX E; GRANGEOTKEROS I; GRATACAPCAVALLIER B; HENQUELL C; LEGRANDQUILLIEN MC; NOVILLO A; PALMER P; PETITJEAN J; SANDRES K; DUBREUIL P; FLEURY H; FREYMUTH F; LEPARCGOFFART I; HOBER D; IZOPET J; KOPECKA H; LAZIZI Y; LAFEUILLE H; LEBON P; ROSETO A; MARCHADIER E; MASQUELIER B; PICARD B; PUEL J; SEIGNEURIN JM; WATTRE P; AYMARD M
      MULTICENTER EVALUATION OF A COMMERCIALLY AVAILABLE PCR ASSAY FOR DIAGNOSING ENTEROVIRUS INFECTION IN A PANEL OF CEREBROSPINAL-FLUID SPECIMENS

      Journal of clinical microbiology
    82. ROSTAING L; RUMEAU JL; CISTERNE JM; IZOPET J; CHABANNIER MH; DURAND D
      LIVER HISTOLOGY IN RENAL-TRANSPLANT PATIENTS AFTER MORE THAN 10 YEARSOF HEPATITIS-C VIRUS-INFECTION

      Transplantation proceedings
    83. ROSTAING L; IZOPET J; CISTERNE JM; BARON E; RUMEAU JL; CHABANNIER MH; DUFFAUT M; DURAND D
      TREATMENT OF CHRONIC HEPATITIS-B AND HEPATITIS-C WITH ALPHA-INTERFERON IN A RENAL-TRANSPLANT PATIENT

      Scandinavian journal of urology and nephrology
    84. IZOPET J; ROSTAING L; MOUSSION F; THAT HT; PAYEN JL; SAYADA C; DUFFAUT M; GIROLAMI JP; DURAND D; PUEL J; PUPAN CHU; RANGUEIL CHU
      LONG-TERM VIROLOGICAL RESPONSE AFTER ALPHA-INTERFERON THERAPY IN HCV-POSITIVE HEMODIALYSIS-PATIENTS

      Journal of the American Society of Nephrology
    85. IZOPET J; ROSTAING L; THAT HT; VERNIER I; MOUSSION F; ROSSIGNOL ME; DUPRE C; HENRY S; GIROLAMI JP; ICART J; DURAND D; PUEL J
      INCIDENCE OF HCV INFECTION IN HEMODIALYSIS UNITS WITH OR WITHOUT PATIENTS ISOLATION

      Journal of the American Society of Nephrology
    86. ROSTAING L; RUMEAU JL; CISTERNE JM; IZOPET J; GIROLAMI JP; CHABANNIER MH; DURAND D
      LIVER HISTOLOGY IN RENAL-TRANSPLANT PATIENTS AFTER MORE THAN 10 YEARSOF HCV INFECTION

      Journal of the American Society of Nephrology
    87. ROSTAING L; IZOPET J; BARON E; DUFFAUT M; PUEL J; DURAND D; SUC JM
      PRELIMINARY-RESULTS OF TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT INTERFERON-ALPHA IN RENAL-TRANSPLANT PATIENTS

      Nephrology, dialysis, transplantation
    88. TRICOIRE J; CLAEYSSENS S; BERREBI A; IZOPET J; ROLLAND M
      EARLY HEMATOLOGICAL CONSEQUENCES SEEN IN INFANTS BORN TO MOTHERS GIVEN ZIDOVUDINE DURING PREGNANCY

      Archives de pediatrie
    89. IZOPET J; PAYEN JL; ALRIC L; SELVES J; DUBOIS M; HENRY S; ICART J; MULARCZYK M; BARANGE K; COMBIS JM; DESMORAT H; VINEL JP; SAINTMARCGIRARDIN MF; VOIGT JJ; SAVADA C; DUFFAUT M; PASCAL JP; PUEL J
      BASE-LINE LEVEL AND KINETICS OF HCV VIREMIA DURING INTERFERON THERAPYARE RELATED TO HCV GENOTYPE

      Hepatology
    90. IZOPET J; PAYEN JL; ALRIC L; CAZABAT M; DUBOIS M; SAYADA C; DUFFAUT M; PASCAL JP; PUEL J
      HCV RNA QUANTITATION USING RT-PCR (MONITOR(TM)) OR BRANCHED DNA (QUANTIPLEX(TM)) OR AS A PREDICTIVE MARKER OF RESPONSE OR NONRESPONSE TO INFERFERON

      Hepatology
    91. PAYEN JL; IZOPET J; IMANI K; ALRIC L; BARANGE K; DUFFAUT M; VINEL JP; PASCAL JP; PUEL J
      RETREATMENT OF CHRONIC HEPATITIS-B (CH HBV) WITH ALPHA-2 INTERFERON (IFN) IN NONRESPONDERS AND RELAPSE PATIENTS IS EFFICIENT

      Hepatology
    92. BOGARD M; IZOPET J; LOUVET M; DUSSAIX E; DUBOIS M; GOURMELIN Y; DEMACHY MC; PUEL J; THUILLIER F; SAYADA C
      ANALYTICAL EVALUATION OF THE AMPLICOR(TM) HEPATITIS-C VIRUS (HCV) RNAMONITOR(TM) QUANTITATIVE ASSAY

      Hepatology
    93. IZOPET J; PAYEN JL; CAZABAT M; DUBOIS M; THOUVENOT JP; PASCAL JP; SAYADA C; PUEL J
      RIBA-3 OR PCR AS A COMPLEMENTARY TEST TO ESTABLISH THE DIAGNOSIS OF HCV INFECTION IN A CLINICAL VIROLOGY LABORATORY

      Hepatology
    94. PAYEN JL; IZOPET J; IMANI K; ALRIC L; BARANGE K; DUFFAUT M; VINEL JP; PASCAL JP; PUEL J
      CIRRHOSIS DOESNT INFLUENCE RESPONSE TO INTERFERON THERAPY OF CHRONIC HEPATITIS-B

      Hepatology
    95. ROSTAING L; IZOPET J; BARON E; DUFFAUT M; PUEL J; DURAND D
      TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT ALPHA-2B-INTERFERONIN KIDNEY-TRANSPLANT RECIPIENTS - PRELIMINARY-RESULTS AND SIDE-EFFECTS

      Transplantation proceedings
    96. ROSTAING L; IZOPET J; BARON E; DUFFAUT M; PUEL J; DURAND D
      TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT INTERFERON-ALPHA INKIDNEY-TRANSPLANT RECIPIENTS

      Transplantation
    97. IZOPET J; ROSTAING L; CAZABAT M; DUBOIS M; SAYADA C; DUFFAUT M; BARON E; GIROLAMI JP; DURAND D; PUEL J
      FAILURE OF HCV RNA CLEARANCE IN KIDNEY-TRANSPLANT RECIPIENTS TREATED WITH ALPHA-INTERFERON

      Journal of the American Society of Nephrology
    98. ROSTAING L; RUMEAU JL; BARON E; DUFFAUT M; IZOPET J; DELISLE MB; DURAND D; SUC JM
      LIVER PATHOLOGY AFTER INTERFERON-ALPHA THERAPY IN CHRONIC HEPATITIS-CINFECTION IN RENAL-TRANSPLANT PATIENTS

      Journal of the American Society of Nephrology
    99. PAYEN JL; IZOPET J; SELVES J; DEBZI N; PAYEN C; VOIGT JJ; COMBIS JM; VINEL JP; DUFFAUT M; PASCAL JP; PUEL J
      PREDICTIVE FACTORS OF RELAPSE AFTER INTERFERON THERAPY (3-MU TIW FOR 6 MONTHS) IN PATIENTS TREATED FOR CHRONIC HCV INFECTION

      Hepatology
    100. IZOPET J; ROSTAING L; DUBOIS M; CAZABAT M; SAYADA C; DUFFAUT M; BARON E; GIROLAMI JP; DURAND D; PUEL J
      FAILURE OF HCV RNA CLEARANCE IN KIDNEY-TRANSPLANT RECIPIENTS TREATED WITH ALPHA-INTERFERON

      Hepatology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 18:44:17